Purple Biotech (PPBT) Share-based Compensation (2014 - 2026)
Purple Biotech (PPBT) recorded Share-based Compensation of $67,000 in Q2 2026, up 13.6% from $59,000 a year earlier but down 28.0% from the prior quarter.
Powered by 
Analysis
Purple Biotech (PPBT) Share-based Compensation (2014 - 2026) Analysis & Trends
On a TTM basis, Purple Biotech's Share-based Compensation came in at $317,000 as of Jun 30, 2026, up 26.8% year-over-year; for FY2025, it was $309,000, down 46.9% from FY2024.
- Annual Share-based Compensation has declined for three straight years, with a five-year compound annual growth rate of -34.9% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $582,000 in FY2024 (-69.0%), $1.88 million in FY2023 (-22.3%), $2.41 million in FY2022 (+15.9%) and $2.08 million in FY2021 (-21.3%).
- Quarterly Share-based Compensation has ranged from -$43,000 in Q4 2025 to $839,000 in Q4 2022 over the past five years.
- On a year-over-year basis, Share-based Compensation rose in two of the last six quarters, with an average decline of 23.9%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 175.1% in Q4 2022, against a decline of 78.4% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $93,000 (Q1 2026), -$43,000 (Q4 2025) and $200,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Purple Biotech | 249,214.64 | 191,214.64 | - | 67,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67,000.00 |
| Mar 31, 2026 | 93,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 59,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | -34,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Dec 31, 2023 | 181,000.00 |
| Sep 30, 2023 | 449,000.00 |
| Jun 30, 2023 | 493,000.00 |
| Mar 31, 2023 | 752,000.00 |
| Dec 31, 2022 | 839,000.00 |
| Sep 30, 2022 | 707,000.00 |
| Jun 30, 2022 | 557,000.00 |
| Mar 31, 2022 | 309,000.00 |
| Dec 31, 2021 | 305,000.00 |
| Sep 30, 2021 | 392,000.00 |
API Access
Purple Biotech Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PPBT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "PPBT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PPBT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();